Lung Nodules
Conditions
Interventions
Control group:Conventional endoscope movement techniques
Experimental group:Pressure-free endoscope movement techniques
Sponsors
Shandong Provincial Hospital, Shandong Children's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18–75 years; 2. Patients with pulmonary nodules scheduled for thoracoscopic surgery; 3. Voluntarily participate in this clinical trial and sign the informed consent form;
Exclusion criteria
Exclusion criteria: 1.Patients with a history of thoracic surgery at the planned surgical access site or ipsilateral thorax, making thoracoscopic surgery unsuitable; 2.Patients with severe cardiac, pulmonary, hepatic, or renal dysfunction who cannot tolerate surgery; 3.Patients with a high bleeding tendency or coagulation abnormalities (APTT = 1.5 times the upper limit of normal), long-term use of anticoagulants or antiplatelet agents, or those who discontinued anticoagulant/antiplatelet medications less than one week before surgery (except for prophylactic low-molecular-weight heparin); 4.Patients with epilepsy or cognitive impairment; 5.Patients with suspected or confirmed drug addiction; 6.Pregnant or breastfeeding women, or those planning pregnancy within the next 6 months; 7.Patients who participated in other interventional medical device clinical trials within 1 month before this trial or were within 5 half-lives of the last dose in a drug clinical trial; 8.Patients deemed unsuitable for participation by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Assessment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative Quality of Life (QOL) Scores;Surgical Treatment Evaluation; | — |
Countries
China
Contacts
Public ContactJiajun Du
Shandong Provincial Hospital, Shandong Children's Hospital
Outcome results
None listed